Day: November 23, 2021

BETHESDA, Md., Nov. 23, 2021 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST), the nation’s largest lodging real estate investment trust (the “Company”), has been named to the Dow Jones Sustainability World Index (DJSI World) for the third year in a row, maintaining its position as a global sustainability leader. Additionally, the Company has been included in the DJSI North America for the fifth consecutive year.  The DJSI World is comprised of corporate leaders in global sustainability across all industries and represents the top 10% of the largest 2,500 companies in the S&P Global Broad Market Index based on long-term economic and environmental, social and governance (ESG) criteria. The Company was one of only five U.S. real estate companies to make this prestigious list. “At Host, we have integrated corporate...

IRVINE, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in the following virtual investor conferences:Ophthalmology Day at BTIG on Tuesday, November 30, 2021 Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1-2, 2021The above listed dates are subject to change. Please check www.tarsusrx.com for the latest information. About Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range...

HOUSTON, Nov. 23, 2021 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby” or “the Company”) (NYSE: KEX) announced today that Kirby will present in a fireside chat at the Stephens NASH2021 Investment Conference on Wednesday, December 1, 2021. Specifics of the conference presentation are as follows:Stephens NASH2021 Investment ConferenceDate:    Wednesday, December 1, 2021Time:   4:00 p.m. Eastern / 3:00 p.m. CentralPresenters:   David Grzebinski, President and CEORaj Kumar, Executive Vice President and CFOModerator:   Jack Atkins, Stephens Managing DirectorLocation:   Nashville, TennesseeWebcast:    KEX – Stephens NASH2021 Investor Conference Fireside ChatThe live audio of the presentation will be broadcast to the public via a webcast with a replay available for 30 days by visiting Kirby’s website...

PITTSBURGH, Nov. 23, 2021 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI), a leader in engineered materials and optoelectronic components, today announced that Dr. Julie Sheridan Eng and Chris Cole have been elected by the Optica Board of Directors to its 2022 Fellows Class. Julie is Senior Vice President & General Manager, Optoelectronic Devices & Modules Business Unit, for II-VI, and Chris is II-VI Adviser. Optica Fellows are members of Optica (formerly the Optical Society of America, OSA) who have served with distinction in the advancement of optics and photonics through their sustained contributions to education, research, engineering, business, and society. Fellows are elected annually by the Optica Board of Directors in a highly competitive process. “The election of Julie and Chris to the distinguished ranks...

PALM BEACH GARDENS, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) today announced that its senior management will present in a virtual fireside chat format at the Wells Fargo 5th Annual TMT Summit on Tuesday, November 30, 2021 at 8:00 a.m. ET. Dycom’s senior management will also participate in virtual one-on-one meetings throughout the day. A live audio webcast of the fireside chat will be available in the Events and Presentations section of Dycom’s Investor Center website at https://ir.dycomind.com. A replay of the webcast will be available for approximately 30 days. About Dycom Industries, Inc. Dycom is a leading provider of specialty contracting services throughout the United States. These services include program management; planning; engineering and design; aerial, underground, and wireless...

ISELIN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 8,000,000 shares of common stock of Outlook Therapeutics, at a price to the public of $1.25 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about November 29, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. Outlook...

LITTLE ROCK, Ark., Nov. 23, 2021 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior Vice President, Chief Financial Officer and Treasurer, Paul Bullington, and Vice President, Finance and Investor Relations, Bill DiTullio, are scheduled to participate at the Barclays 2021 Global Technology, Media and Telecommunications Conference. The presentation is scheduled for 4:45 PM ET on December 7, 2021. You may access a live webcast of the virtual event on Uniti’s website at www.uniti.com under the Investors tab. The webcast will be available for replay for a limited time on Uniti’s website following the presentation. ABOUT UNITI Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading...

SOUTH ORANGE, NJ, Nov. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Benchmark Company 10th Annual One-on-One Discovery Conference. The conference is taking place virtually on December 2, 2021, in a one-on-one and small group meeting format. The invitation-only event is for institutional clients of the Benchmark Company. For additional details, please contact Director of Corporate Access, Vince Curatola, at 414-203-5556. About the Benchmark Company The Benchmark Company is an institutionally focused, research driven, sales, trading & investment banking firm. Over...

PERRYSBURG, Ohio, Nov. 23, 2021 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE O-I Glass, Inc. (NYSE: OI) today announced the Company will participate in The Citi’s 2021 Basic Materials Virtual Conference on Tuesday, November 30, 2021. O-I Chief Executive Officer Andres Lopez and Chief Financial Officer John Haudrich will present at 8:45 a.m. ET. A live webcast of the presentation will be available at: https://kvgo.com/citi-2021-basic-materials/o-i-glass-november The replay will be available through the above link within 24 hours of the presentation and will be archived for 90 days following the completion of the conference. Slides from the presentation will be posted on the Company’s website, https://investors.o-i.com/webcasts-presentations, after the market closes on November 29. ### About O-I Glass At O-I Glass, Inc. (NYSE: OI),...

HAMILTON, Bermuda, Nov. 23, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 12:10 p.m. Eastern Time. A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours after the event. About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s portfolio of assets, ARCALYST® (rilonacept), mavrilimumab, vixarelimab...